Single-cell suspensions from the GC tissues, adjacent normal tissues, and blood were washed with FACS-staining buffer (PBS with 0.5% BSA and 0.1% sodium azide) and then incubated with amine-reactive dead cell stain (L34961; Thermo Fisher Scientific, Waltham, MA, USA) for 30 min on ice. After another wash, the cells were stained with the following fluorescent-conjugated anti-human surface Abs for 20 min at 4oC: anti-human CD206 (19.2), anti-human CD11c (B-ly6), anti-human CD86 (IT2.2), anti-human CD15 (W6D3), anti-human CD68 (Y1/82A), anti-human CD66b (WM-53), anti-human CD14 (M5E2), anti-human CD16 (3G8), anti-human CD33 (G10F5), anti-human HLA-DR (L243), anti-human CD45 (HI30), anti-human CD11b (ICRF44), anti-human CD274 (MIH1), anti-human CXCR4 (12G5), anti-human CD56 (NCAM16.2), anti-human CD25 (2A3), anti-human CD19 (HIB19), anti-human CD8a (RPA-T8), anti-human CD4 (RPA-T4), anti-human Foxp3 (206D), anti-human NKP46 (9E2), anti-human PD-1 (EH12.2H7), anti-human IL-17A (BL-168), anti-human IFN-γ (4S.B3), anti-human TNF-α (Mab11), anti-human granzyme B (GB11). To stain intracellular Ags, the cells were first fixed and permeabilized with IC fixation buffer (00-8222-79; eBioscience, San Diego, CA, USA) and 1× permeabilization buffer (00-8333-56; eBioscience). The fixed and permeabilized cells were then stained with fluorescent-conjugated intracellular Abs for 1 hr at room temperature. For nuclear Foxp3 staining, the Foxp3 staining kit was used according to the manufacturer's instructions (00-5523-00; eBioscience). For intracellular cytokine staining, the cells were first stimulated in the presence of brefeldin A (420601; Biolegend) with 50 ng/ml PMA (P1585; Sigma) and 500 ng/ml ionomycin (I0634; Sigma) for 4 h in a 37°C 5% CO2 incubator. All stained cells were washed and filtered through a 40-μm cell strainer and then analyzed on a LSRFortessa (BD Biosciences) or a FACSymphony A3 (BD Biosciences) flow cytometer.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.